Halozyme Therapeutics HALO revenue climbs 375 YoY despite steep earnings miss investors parse guidance amid cost concerns Market Pulse Tech leads modest market gains while consumer sector trails BRKRP Bruker Corporation 6375 Mandatory Convertible Preferred Stock Series A rises 408 percent even as Q4 2025 earnings miss analyst consensus estimates OneIM OIMAU Stock VWAP Deviation Consolidates 20260418